Titre : Thiosulfates

Thiosulfates : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cognitive Dysfunction
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Thiosulfates : Questions médicales les plus fréquentes", "headline": "Thiosulfates : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Thiosulfates : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-16", "dateModified": "2025-04-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Thiosulfates" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Sulfates", "url": "https://questionsmedicales.fr/mesh/D013431", "about": { "@type": "MedicalCondition", "name": "Sulfates", "code": { "@type": "MedicalCode", "code": "D013431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D01.875.800.800.850" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Thiosulfate d'or et de sodium", "alternateName": "Gold Sodium Thiosulfate", "url": "https://questionsmedicales.fr/mesh/D012971", "about": { "@type": "MedicalCondition", "name": "Thiosulfate d'or et de sodium", "code": { "@type": "MedicalCode", "code": "D012971", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D01.875.800.800.850.900.250" } } } ], "about": { "@type": "MedicalCondition", "name": "Thiosulfates", "alternateName": "Thiosulfates", "code": { "@type": "MedicalCode", "code": "D013885", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Harry van Goor", "url": "https://questionsmedicales.fr/author/Harry%20van%20Goor", "affiliation": { "@type": "Organization", "name": "University Medical Center Groningen, Department of Pathology and Medical Biology the Netherlands. Electronic address: h.van.goor@umcg.nl." } }, { "@type": "Person", "name": "Matthew R Groves", "url": "https://questionsmedicales.fr/author/Matthew%20R%20Groves", "affiliation": { "@type": "Organization", "name": "Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands." } }, { "@type": "Person", "name": "Zayana M Al-Dahmani", "url": "https://questionsmedicales.fr/author/Zayana%20M%20Al-Dahmani", "affiliation": { "@type": "Organization", "name": "Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands." } }, { "@type": "Person", "name": "Jaap A Joles", "url": "https://questionsmedicales.fr/author/Jaap%20A%20Joles", "affiliation": { "@type": "Organization", "name": "University Medical Center Utrecht, Department of Nephrology and Hypertension, the Netherlands." } }, { "@type": "Person", "name": "Amalia M Dolga", "url": "https://questionsmedicales.fr/author/Amalia%20M%20Dolga", "affiliation": { "@type": "Organization", "name": "University of Groningen, Department of Pharmacy, Molecular Pharmacology, the Netherlands." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36251860", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/13506129.2022.2131384" } }, { "@type": "ScholarlyArticle", "name": "Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.", "datePublished": "2024-09-13", "url": "https://questionsmedicales.fr/article/39346594", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1385089" } }, { "@type": "ScholarlyArticle", "name": "Reward network dysfunction is associated with cognitive impairment after stroke.", "datePublished": "2023-05-31", "url": "https://questionsmedicales.fr/article/37307650", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.nicl.2023.103446" } }, { "@type": "ScholarlyArticle", "name": "Predictors of cognitive dysfunction one-year post COVID-19.", "datePublished": "2023-01-05", "url": "https://questionsmedicales.fr/article/36603126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1037/neu0000876" } }, { "@type": "ScholarlyArticle", "name": "Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.", "datePublished": "2022-12-07", "url": "https://questionsmedicales.fr/article/36729842", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/RHU.0000000000001888" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Produits chimiques inorganiques", "item": "https://questionsmedicales.fr/mesh/D007287" }, { "@type": "ListItem", "position": 3, "name": "Sulfates", "item": "https://questionsmedicales.fr/mesh/D013431" }, { "@type": "ListItem", "position": 4, "name": "Thiosulfates", "item": "https://questionsmedicales.fr/mesh/D013885" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Thiosulfates - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Thiosulfates", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Thiosulfates", "description": "Comment diagnostiquer une intoxication aux thiosulfates ?\nQuels tests sont utilisés pour évaluer les thiosulfates ?\nQuels symptômes indiquent une intoxication aux thiosulfates ?\nY a-t-il des marqueurs biologiques pour les thiosulfates ?\nComment différencier les thiosulfates d'autres composés ?", "url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Cognitive+Dysfunction&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Thiosulfates", "description": "Quels sont les symptômes courants d'une intoxication ?\nLes thiosulfates provoquent-ils des effets secondaires ?\nComment les thiosulfates affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes thiosulfates affectent-ils le système digestif ?", "url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Cognitive+Dysfunction&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Thiosulfates", "description": "Comment prévenir une intoxication aux thiosulfates ?\nY a-t-il des mesures de sécurité en milieu professionnel ?\nLes thiosulfates peuvent-ils être évités dans certains aliments ?\nQuelles sont les recommandations pour les travailleurs exposés ?\nLes thiosulfates sont-ils réglementés ?", "url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Cognitive+Dysfunction&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Thiosulfates", "description": "Quel est le traitement principal pour l'intoxication aux thiosulfates ?\nLes thiosulfates sont-ils utilisés en médecine préventive ?\nY a-t-il des antidotes pour les thiosulfates ?\nComment administrer les thiosulfates en cas d'urgence ?\nLes thiosulfates sont-ils efficaces contre toutes les intoxications ?", "url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Cognitive+Dysfunction&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Thiosulfates", "description": "Quelles complications peuvent survenir après une intoxication ?\nLes thiosulfates peuvent-ils causer des dommages permanents ?\nY a-t-il des risques de rechute après traitement ?\nComment surveiller les complications post-intoxication ?\nLes complications sont-elles prévisibles ?", "url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Cognitive+Dysfunction&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Thiosulfates", "description": "Quels sont les facteurs de risque d'intoxication aux thiosulfates ?\nLes enfants sont-ils plus à risque d'intoxication ?\nY a-t-il des conditions médicales qui augmentent le risque ?\nLes personnes âgées sont-elles plus à risque ?\nComment évaluer le risque d'exposition aux thiosulfates ?", "url": "https://questionsmedicales.fr/mesh/D013885?mesh_terms=Cognitive+Dysfunction&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux thiosulfates ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical et des tests sanguins pour mesurer les niveaux de thiosulfate." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les thiosulfates ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter les thiosulfates." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication aux thiosulfates ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements, et des troubles respiratoires." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les thiosulfates ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés de thiosulfate dans le sang peuvent indiquer une intoxication." } }, { "@type": "Question", "name": "Comment différencier les thiosulfates d'autres composés ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests chimiques spécifiques peuvent identifier les thiosulfates parmi d'autres composés." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une intoxication ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées, et des troubles neurologiques." } }, { "@type": "Question", "name": "Les thiosulfates provoquent-ils des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des démangeaisons ou des éruptions cutanées peuvent survenir." } }, { "@type": "Question", "name": "Comment les thiosulfates affectent-ils le système respiratoire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des difficultés respiratoires en cas d'intoxication sévère." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les enfants ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes plus graves, comme des convulsions." } }, { "@type": "Question", "name": "Les thiosulfates affectent-ils le système digestif ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent causer des nausées, des vomissements et des douleurs abdominales." } }, { "@type": "Question", "name": "Comment prévenir une intoxication aux thiosulfates ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez l'exposition à des sources connues de thiosulfates et suivez les consignes de sécurité." } }, { "@type": "Question", "name": "Y a-t-il des mesures de sécurité en milieu professionnel ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des équipements de protection individuelle doivent être utilisés lors de la manipulation." } }, { "@type": "Question", "name": "Les thiosulfates peuvent-ils être évités dans certains aliments ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains aliments peuvent contenir des thiosulfates; il est conseillé de les limiter si nécessaire." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les travailleurs exposés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des formations sur les risques et l'utilisation d'équipements de protection sont essentielles." } }, { "@type": "Question", "name": "Les thiosulfates sont-ils réglementés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation est souvent réglementée pour minimiser les risques d'intoxication." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication aux thiosulfates ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste en l'administration de thiosulfate de sodium par voie intraveineuse." } }, { "@type": "Question", "name": "Les thiosulfates sont-ils utilisés en médecine préventive ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être utilisés pour prévenir les effets de certaines intoxications." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour les thiosulfates ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le thiosulfate de sodium est souvent utilisé comme antidote pour les intoxications au cyanure." } }, { "@type": "Question", "name": "Comment administrer les thiosulfates en cas d'urgence ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils doivent être administrés par un professionnel de santé, généralement par voie intraveineuse." } }, { "@type": "Question", "name": "Les thiosulfates sont-ils efficaces contre toutes les intoxications ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur efficacité est spécifique à certaines intoxications, comme celle au cyanure." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et respiratoires peuvent survenir si non traitées." } }, { "@type": "Question", "name": "Les thiosulfates peuvent-ils causer des dommages permanents ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une intoxication sévère peut entraîner des dommages neurologiques permanents." } }, { "@type": "Question", "name": "Y a-t-il des risques de rechute après traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des rechutes peuvent se produire si l'exposition aux thiosulfates se poursuit." } }, { "@type": "Question", "name": "Comment surveiller les complications post-intoxication ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier est nécessaire pour détecter d'éventuelles complications." } }, { "@type": "Question", "name": "Les complications sont-elles prévisibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être prévisibles en fonction de la gravité de l'intoxication." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'intoxication aux thiosulfates ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et ceux manipulant des produits contenant des thiosulfates sont à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque d'intoxication ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus vulnérables en raison de leur taille et de leur métabolisme." } }, { "@type": "Question", "name": "Y a-t-il des conditions médicales qui augmentent le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines conditions, comme les maladies respiratoires, peuvent augmenter le risque d'intoxication." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir un métabolisme plus lent, augmentant le risque d'intoxication." } }, { "@type": "Question", "name": "Comment évaluer le risque d'exposition aux thiosulfates ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation des conditions de travail et des habitudes de vie peut aider à évaluer le risque." } } ] } ] }

Sources (10000 au total)

Predictors of cognitive dysfunction in hereditary transthyretin amyloidosis with liver transplant.

Cognitive dysfunction is part of the broad spectrum of clinical manifestations in older untreated hereditary transthyretin amyloidosis patients with peripheral polyneuropathy.... The objective of this study is to systematically explore cognitive dysfunction in ATTRV30M amyloidosis patients whose disease course was modified by liver transplant (LT).... A series of 269 carriers of TTRVal30Met mutation treated with LT underwent a neuropsychological assessment. Clinical charts were reviewed to identify focal neurological episodes (FNEs), cognitive comp... Cognitive dysfunction was identified in 35 patients (13%)-14 (5%) had mild and 21 (8%) had moderate dysfunction. In comparison to normal cognition, both mild and moderate cognitive dysfunction patient... Consistent with the natural history of the disease, older age and higher severity of the disease are significantly associated and potentially predictors of cognitive dysfunction in ATTRV30M patients t...

Risk factors for cognitive dysfunction amongst patients with cardiovascular diseases.

The impact of cardiovascular diseases on cognition raises important research questions. The study aimed to investigate the relationship between demographic data, cardiovascular diseases, kidney diseas... A cross-sectional study of patients with cardiovascular diseases was performed. The Montreal Cognitive Assessment (MoCA) was applied for cognitive evaluation. Based on MoCA three groups were defined: ... Of 628 patients, 55.2% had mild CD, and the mean age was 67.95 (SD 9.53) years. Cα and Mω were 0.7, indicating good internal consistency. We found a moderate positive correlation between depression an... Mild CD was the most common in patients with cardiovascular diseases. Older age, lower education, being a non-smoker, and renal dysfunction were risk factors for both mild and advanced CD. Female gend...

Predictors of cognitive dysfunction one-year post COVID-19.

(a) To characterize the frequency of objective cognitive deficits and self-perceived cognitive difficulties and (b) to explore demographic and clinical predictors of cognitive dysfunction and cognitiv... One hundred and ten adults diagnosed with COVID-19 between March and November 2020, aged ≤ 74 years underwent a brief neuropsychological evaluation 12 months after infection, which included: Brief Vis... Twenty participants (18.2%) had cognitive dysfunction and 36 (33.3%) had cognitive complaints. Cognitive dysfunction was related to lower education, preinfection history of headache/migraine, and acut... A subset of individuals develops cognitive difficulties in the context of post-COVID syndrome. Results may support the protective effect of education, a known proxy of cognitive reserve. COVID-19 infe...

Cognitive Dysfunction Biomarkers in Patients With Rheumatoid Arthritis: A Systematic Review.

During the last years, a growing number of studies have investigated the link between cognitive dysfunction and rheumatoid arthritis (RA), highlighting the potential pathogenic role of several clinica... We performed a systematic review using PRISMA (Preferred Reported Items for Systematic Reviews and Meta-analysis) protocol. A systematic search was conducted in the PubMed/MEDLINE, EMBASE, LILACS, Sco... Five original studies were included, which provided data from 428 participants. Among plasma proteins, SHH was increased and TTR was reduced in patients with mild cognitive impairment; anti-myelin bas... Despite the relative scarcity of studies on this subject and the heterogeneity of results, we identified possible biomarkers for cognitive deficits in the RA population. Further longitudinal studies a...

Endothelial Dysfunction and Pre-Existing Cognitive Disorders in Stroke Patients.

The origin of pre-existing cognitive impairment in stroke patients remains controversial, with a vascular or a degenerative hypothesis.... To determine whether endothelial dysfunction is associated with pre-existing cognitive problems, lesion load and biological anomalies in stroke patients.... Patients originated from the prospective STROKDEM study. The baseline cognitive state, assessed using the IQ-CODE, and risk factors for stroke were recorded at inclusion. Patients with an IQ-CODE scor... A total of 86 patients were included (52 males; mean age 63.5 ± 11.5 years). Patients with abnormal RHI have hypertension or antihypertensive treatment more often. The baseline IQ-CODE was abnormal in... A vascular mechanism may be responsible for cognitive problems pre-existing stroke. The measurement of endothelial dysfunction after stroke could become an important element of follow-up, providing an...

Cognitive Dysfunction in Heart Failure: Pathophysiology and Implications for Patient Management.

There is increasing recognition of the prevalence and impact of cognitive dysfunction (CD) in heart failure (HF) patients. This contemporary review appraises the evidence for epidemiological associati... CD disproportionately affects heart failure patients, even accounting for known comorbid risk factors, and this may extend to subclinical left ventricular dysfunction. Neuroimaging studies now provide...

Frequency and risk factors for cognitive dysfunction in peritoneal dialysis patients.

There is limited data on cognition in patients undergoing peritoneal dialysis (PD). We assessed prevalence and associated risk factors of neurocognitive impairment (NCI) in PD patients.... A cross-sectional cohort study of 149 PD patients at a single centre between 2016 and 2020 who underwent neurocognitive screening at defined intervals by Addenbrooke's Cognitive Examination - Revised ... Patients on PD performed poorly in ACE-R screening compared to population norms, with discrepancy in all cognitive domains. In patients without CVD, attention and language domains were comparable to n... Patients on PD have higher prevalence of NCI than the general population, primarily with impairments in memory, fluency and visuospatial reasoning. CVD confers poorer performance in attention and lang...